<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:chebi fb="0" ids="30314">Lipoic acid</z:chebi> synthase (LASY) is the enzyme that is involved in the endogenous synthesis of <z:chebi fb="0" ids="30314">lipoic acid</z:chebi>, a potent <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="11" ids="22586">antioxidant</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to study the role of LASY in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We studied expression of LASY in animal models of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We also looked at regulation of LASY in vitro under conditions that exist in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, we looked at effects of LASY knockdown on cellular <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status, <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function, and insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: LASY expression is significantly reduced in tissues from animal models of <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo> compared with age- and sex-matched controls </plain></SENT>
<SENT sid="6" pm="."><plain>In vitro, LASY <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were decreased by the proinflammatory cytokine <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha and high <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Downregulation of the LASY gene by <z:chebi fb="40" ids="33697">RNA</z:chebi> interference (RNAi) reduced endogenous levels of <z:chebi fb="0" ids="30314">lipoic acid</z:chebi>, and the activities of critical components of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense network, increasing <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment with exogenous <z:chebi fb="0" ids="30314">lipoic acid</z:chebi> compensated for some of these defects </plain></SENT>
<SENT sid="9" pm="."><plain>RNAi-mediated downregulation of LASY induced a significant loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential and decreased insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake in skeletal muscle cells </plain></SENT>
<SENT sid="10" pm="."><plain>In endothelial cells, downregulation of LASY aggravated the <z:mp ids='MP_0001845'>inflammatory response</z:mp> that manifested as an increase in both basal and TNF-alpha-induced expression of the proinflammatory cytokine, monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1) </plain></SENT>
<SENT sid="11" pm="."><plain>Overexpression of the LASY gene ameliorated the <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Deficiency of LASY results in an overall disturbance in the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense network, leading to increased <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction </plain></SENT>
</text></document>